Axsome Therapeutics, Inc

Go to Axsome Therapeutics, Inc Website

$102.44

-4.11 (-3.85%)
Live
Previous Close

$106.54

Day Range

$102.33 - $106.99

Previous Day Range

$96.09 - $109.88

Market Cap

$5.1 billion USD

Day Vol.

380809

Previous Day Vol.

1.1 million

Currency

USD

Primary Exchange

Nasdaq

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline product...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Axsome Therapeutics is joining the Alzheimer's disease advocacy community to raise awareness of the growing impact of Alzheimer's disease in the United States and the importance of brain health during Alzheimer's & Brain Awareness Month.

Related tickers: AXSM.

Read Full Article

Axsome Therapeutics presented multiple studies on its sleep disorder treatments AXS-12 and solriamfetol at the SLEEP 2025 conference, showcasing the company's innovation in this therapeutic area.

Related tickers: AXSM.

Read Full Article
Trending Tickers

Please sign in to view